Novel inhibitors that target bacterial virulence identified via HTS against intra-macrophage survival of Shigella flexneri by Marija Miljkovic, Sonia Lozano, Isabel Castellote, Cristina de Cózar, Ana I. Villegas-Moreno, Pablo Gamallo, Dolores Jimenez-Alfaro Martinez, Elena Fernández-Álvaro, Lluis Ballell, George A. Garcia

Get full text

Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol by Subhasish Das, Tahmeed Ahmed, Juliet Addo, Firdausi Qadri, Rachel Gibson, Patricia B Pavlinac, Md Jobayer Chisti, Farhana Khanam, Dilruba Ahmed, Sharika Nuzhat, Md Ridwan Islam, Syed Jayedul Bashar, Samuel L Arnold, Amy Newlands, Elena Fernandez Alvaro

Get full text

Correction: The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp by Elena Fernández Álvaro, Phat Voong Vinh, Cristina de Cozar, David R Willé, Beatriz Urones, Alvaro Cortés, Alan Price, Nhu Tran Do Hoang, Tuyen Ha Thanh, Molly McCloskey, Shareef Shaheen, Denise Dayao, Amanda Martinot, Jaime de Mercado, Pablo Castañeda, Adolfo García-Perez, Benson Singa, Patricia Pavlinac, Judd Walson, Maria Santos Martínez-Martínez, Samuel LM Arnold, Saul Tzipori, Lluis Ballell Pages, Stephen Baker

Get full text